Medeloop accelerates breakthrough discoveries through novel deep AI model explainability techniques built on top of a comprehensive data linkage infrastructure. Medeloop is a one of a kind platform that seamlessly links, harmonizes, and analyzes massive amounts of health data. We are pioneering AI techniques that find biomarkers for clinical researchers, helping break down barriers to save lives. For Researchers: Our platform shortens the clinical research process using advanced AI techniques that provide research hypotheses for even the most understudied diseases. All of your data, all in one place. Cleaned, organized and analyzed. Medeloop transforms the research approach, enabling researchers to publish more and publish faster. For Research Participants: Our patient-facing app encourages the public to take control of their health and contribute to life-changing medical research. You always have access to view your health information and how it is being utilized.
Location: United States, California, Palo Alto
Employees: 1-10
Total raised: $23.5M
Founded date: 2021
Funding Rounds 2
Date | Series | Amount | Investors |
18.11.2024 | Series A | $15.5M | - |
21.09.2023 | Seed | $8M | - |
Mentions in press and media 8
Date | Title | Description |
18.11.2024 | Medeloop Raises $15.5M in Series A Funding | Medeloop, a Menlo Park, CA-based medical research platform, raised $15.5M in Series A funding. The round was led by Inovia Capital with participation from Icon Ventures, General Catalyst and Maven Ventures, as well as new investors includin... |
14.11.2024 | Medeloop's $15.5 Million Boost: A New Era for Medical Research | In the heart of Silicon Valley, a revolution is brewing. Medeloop, an innovative medical research platform, has secured $15.5 million in Series A funding. This financial windfall is not just a number; it’s a beacon of hope for the future of... |
13.11.2024 | Medeloop Raises $15.5M for AI-Driven Medical Research Platform | What You Should Know: – Medeloop, a pioneering medical research platform, has secured $15.5M in Series A funding to further its mission of revolutionizing medical research through artificial intelligence (AI). – The funding round was led by... |
13.11.2024 | Medeloop Secures $15.5 Million in Series A Funding to Accelerate Medical Research | MENLO PARK, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Medeloop, the pioneering medical research platform announces the close of its $15.5 million Series A funding round. Led by global venture capital firm Inovia Capital and supported by sig... |
13.03.2024 | Medeloop Partners with Mila to Leverage AI in Health Technology | Medeloop is pleased to announce a strategic partnership with Mila- Quebec AI Institute, the world’s largest academic deep learning research center. Founded by a team with Quebec roots, Medeloop is an innovative platform that transforms clin... |
21.09.2023 | Medeloop Raises $8M in Seed Funding | Medeloop, a Palo Alto, CA-based healthtech startup, raised $8M in Seed funding. The round was led by General Catalyst with participation from Maven Ventures, the Ovo Fund, NV investments (led by Vivi Nivo), Ken Frazier (former Chairman and ... |
20.09.2023 | See the 10-slide presentation a startup used to land $8 million from General Catalyst to speed up medical research with AI | Medeloop's cofounders, from left: Josh Walonoski, Rene Caissie, Andy Yakulis, and Raghav Samavedam. Medeloop This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Medeloop just raised $8 millio... |
- | Medeloop | “Medeloop is an end-to-end AI-driven platform for early stage clinical research and trials.” |